<unk> s are a class of drugs that activate<unk> -HT2C<unk> s. They have been investigated for the treatment of a number of conditions including obesity, psychiatric disorders, sexual dysfunction and urinary incontinence. The<unk> -HT2C<unk> s are one of three subtypes that belong to the serotonin<unk> -HT2<unk>  subfamily along with<unk> -HT2A and<unk> -HT2B<unk> s. The development of<unk> -HT2C agonists has been a major obstacle, because of severe side effects due to a lack of selectivity over<unk> -HT2A and<unk> -HT2B<unk> s. Activation of<unk> -HT2A<unk> s can induce hallucinations, and the activation of<unk> -HT2B<unk> s has been implicated in cardiac valvular insufficiency and possibly in pulmonary hypertension.
5-HT2C receptor agonist
Serotonin receptor agonist
Glycine receptor antagonist
Adenosine reuptake inhibitor
Dopamine agonist
Muscarinic antagonist
5-HT3 antagonist
Dopamine antagonist